These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17144519)

  • 41. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
    Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
    Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Retinal sensitivity measured with the micro perimeter 1 after resolution of central serous chorioretinopathy.
    Ojima Y; Tsujikawa A; Hangai M; Nakanishi H; Inoue R; Sakamoto A; Yoshimura N
    Am J Ophthalmol; 2008 Jul; 146(1):77-84. PubMed ID: 18405876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fundus autofluorescence before and after photodynamic therapy for chronic central serous chorioretinopathy.
    Ozmert E; Batioğlu F
    Ophthalmologica; 2009; 223(4):263-8. PubMed ID: 19339810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Birdshot chorioretinopathy.
    Shah KH; Levinson RD; Yu F; Goldhardt R; Gordon LK; Gonzales CR; Heckenlively JR; Kappel PJ; Holland GN
    Surv Ophthalmol; 2005; 50(6):519-41. PubMed ID: 16263368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis).
    Grover S; Murthy RK; Brar VS; Chalam KV
    Am J Ophthalmol; 2009 Aug; 148(2):266-71. PubMed ID: 19427616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optical coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema.
    Gaucher D; Sebah C; Erginay A; Haouchine B; Tadayoni R; Gaudric A; Massin P
    Am J Ophthalmol; 2008 Feb; 145(2):289-296. PubMed ID: 18054885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Associations between macular findings by optical coherence tomography and visual outcomes after epiretinal membrane removal.
    Suh MH; Seo JM; Park KH; Yu HG
    Am J Ophthalmol; 2009 Mar; 147(3):473-480.e3. PubMed ID: 19054492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restored photoreceptor outer segment damage in multiple evanescent white dot syndrome.
    Li D; Kishi S
    Ophthalmology; 2009 Apr; 116(4):762-70. PubMed ID: 19344825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy.
    Meyerle CB; Freund KB; Bhatnagar P; Shah V; Yannuzzi LA
    Retina; 2007 Sep; 27(7):943-6. PubMed ID: 17891021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vitreomacular traction syndrome: impact of anatomical configuration on anatomical and visual outcomes.
    Sonmez K; Capone A; Trese MT; Williams GA
    Retina; 2008 Oct; 28(9):1207-14. PubMed ID: 19430388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Helicobacter pylori--a risk factor for the developement of the central serous chorioretinopathy.
    Misiuk-Hojło M; Michałowska M; Turno-Krecicka A
    Klin Oczna; 2009; 111(1-3):30-2. PubMed ID: 19517842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective retina therapy for acute central serous chorioretinopathy.
    Klatt C; Saeger M; Oppermann T; Pörksen E; Treumer F; Hillenkamp J; Fritzer E; Brinkmann R; Birngruber R; Roider J
    Br J Ophthalmol; 2011 Jan; 95(1):83-8. PubMed ID: 20554506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Idiopathic central serous chorioretinopathy: two case reports observed in Togo].
    Balo KP; Mihluedo H
    Med Trop (Mars); 1996; 56(4):381-3. PubMed ID: 9139198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects].
    Gäckle HC; Lang GE; Freissler KA; Lang GK
    Ophthalmologe; 1998 Aug; 95(8):529-33. PubMed ID: 9782727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ruby laser photocoagulation therapy of central serous retinopathy. I. A controlled clinical study. II. Factors affecting prognosis.
    Watzke RC; Burton TC; Leaverton PE
    Trans Am Acad Ophthalmol Otolaryngol; 1974; 78(2):OP205-11. PubMed ID: 4856872
    [No Abstract]   [Full Text] [Related]  

  • 56. [Case presentation: Unmasking central serous chorioretinopathy].
    Schmidt D
    Klin Monbl Augenheilkd; 1998 Feb; 212(2):aA14. PubMed ID: 9660679
    [No Abstract]   [Full Text] [Related]  

  • 57. [Fundus oculi studies using transformed light in central serous chorioretinopathy].
    Vodovozov AM; Sverdlin SM
    Vestn Oftalmol; 1982; (3):34-6. PubMed ID: 7112849
    [No Abstract]   [Full Text] [Related]  

  • 58. [Birdshot chorioretinopathy: systemic therapy with corticosteroids and nonsteroidal anti-inflammatory drugs].
    Hofmann HM; Feicht B
    Klin Monbl Augenheilkd; 1990 Aug; 197(2):159-61. PubMed ID: 2243477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Birdshot chorioretinopathy.
    Monnet D; Brézin AP
    Curr Opin Ophthalmol; 2006 Dec; 17(6):545-50. PubMed ID: 17065923
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of serum endothelin-1 level in the etiopathogenesis of central serous chorioretinopathy.
    Türkçüoğlu P; Kadayifçilar S; Eldem B
    Am J Ophthalmol; 2006 Aug; 142(2):349-51. PubMed ID: 16876532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.